Literature DB >> 1402662

Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response.

W L Chan1, A Rodgers, R D Hancock, F Taffs, P Kitchin, G Farrar, F Y Liew.   

Abstract

Our earlier reports demonstrated that Cynomolgus macaques vaccinated with either inactivated partially purified simian immunodeficiency virus (SIV), fixed SIV-infected C8166 (a human T lymphoblastoid cell line) cells, or fixed uninfected C8166 cells can be protected against a challenge infection with the 32H isolate of SIVmac 251 (grown in C8166) (Stott, E. J., W. L. Chan, K. H. G. Mills, M. Page, F. Taffs, M. Cranage, P. Greenway, and P. Kitchin. 1990. Lancet. 336:1538; Stott, E. J., P. A. Kitchin, M. Page, B. Flanagan, L. F. Taffs, W. L. Chan, K. H. G. Mills, P. Silvera, and A. Rodgers. 1991. Nature [Lond.]. 353:393). Protection is correlated with the levels of antibody response to cellular antigens in the human cells from which the virus immunogen was grown. However, the mechanism of protection is unclear. We report here the analysis of sera from these protected monkeys and demonstrate that there is positive correlation of protection with antibody response to the HLA class I molecule.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1402662      PMCID： PMC2119400          DOI： 10.1084/jem.176.4.1203

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  16 in total

1.  The ability of certain SIV vaccines to provoke reactions against normal cells.

Authors:  A J Langlois; K J Weinhold; T J Matthews; M L Greenberg; D P Bolognesi
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

2.  AIDS vaccine developments.

Authors:  R Le Grand; B Vaslin; G Vogt; P Roques; M Humbert; D Dormont
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

3.  AIDS vaccine developments.

Authors:  A Osterhaus; P de Vries; J Heeney
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

4.  AIDS research turned upside down.

Authors:  J Maddox
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

5.  The use of the polymerase chain reaction for the detection of Simian immunodeficiency virus in experimentally infected macaques.

Authors:  P A Kitchin; N Almond; Z Szotyori; C E Fromholc; L McAlpine; P Silvera; E J Stott; M Cranage; A Baskerville; G Schild
Journal:  J Virol Methods       Date:  1990-04       Impact factor: 2.014

6.  Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity.

Authors:  M McGrath; O Witte; T Pincus; I L Weissman
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

7.  Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III.

Authors:  L E Henderson; R Sowder; T D Copeland; S Oroszlan; L O Arthur; W G Robey; P J Fischinger
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

8.  A formalin-inactivated whole SIV vaccine confers protection in macaques.

Authors:  M Murphey-Corb; L N Martin; B Davison-Fairburn; R C Montelaro; M Miller; M West; S Ohkawa; G B Baskin; J Y Zhang; S D Putney
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

9.  Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

Authors:  S L Hu; K Abrams; G N Barber; P Moran; J M Zarling; A J Langlois; L Kuller; W R Morton; R E Benveniste
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

10.  Herpes simplex virus infection causes the accumulation of a heat-shock protein.

Authors:  N B LaThangue; K Shriver; C Dawson; W L Chan
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598
View more
  26 in total

1.  Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.

Authors:  Paul W H I Parren; Tom W Geisbert; Toshiaki Maruyama; Peter B Jahrling; Dennis R Burton
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.

Authors:  Joann L Yee; Michael B McChesney; Kari L Christe
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

3.  Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.

Authors:  Andreas Mörner; Marianne Jansson; Evelien M Bunnik; Jørgen Schøller; Robert Vaughan; Yufei Wang; David C Montefiori; Nel Otting; Ronald Bontrop; Lesley A Bergmeier; Mahavir Singh; Richard T Wyatt; Hanneke Schuitemaker; Gunnel Biberfeld; Rigmor Thorstensson; Thomas Lehner
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 4.  Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets.

Authors:  S Phogat; R T Wyatt; G B Karlsson Hedestam
Journal:  J Intern Med       Date:  2007-07       Impact factor: 8.989

5.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

Review 6.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques.

Authors:  Y Wang; L Tao; E Mitchell; W M Bogers; C Doyle; C A Bravery; L A Bergmeier; C G Kelly; J L Heeney; T Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

8.  Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines.

Authors:  M J Hosie; R Osborne; J K Yamamoto; J C Neil; O Jarrett
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge.

Authors:  Surender B Kumar; Sarah Leavell; Kyle Porter; Barnabe D Assogba; Mary J Burkhard
Journal:  Retrovirology       Date:  2010-05-28       Impact factor: 4.602

10.  Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers.

Authors:  W Jennes; D Evertse; M-Y Borget; B Vuylsteke; C Maurice; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.